The tissue factor pathway in disseminated intravascular coagulation
- PMID: 11740684
- DOI: 10.1055/s-2001-18866
The tissue factor pathway in disseminated intravascular coagulation
Abstract
In most instances, tissue factor (TF) exposed to the circulation is the sole culprit underlying the initiation of disseminated intravascular coagulation (DIC), although notable exceptions because of a more direct activation of the coagulation system, by snake venoms, for example, do occur. Peripheral monocytes and subendothelial structures are the potential sources of such TF; in the former, TF emerges on the cell surface on synthesis induction and in the latter it becomes available subsequent to permeability changes or damage to the endothelium. Subendothelial TF is constitutively present in fibroblasts, pericytes, and macrophages and at a higher than normal level in tumor-associated macrophages. This scenario of coagulation activation probably describes the principal events underlying emerging acute DIC states under pathophysiological conditions such as abruptio placentae, septic abortion, amniotic fluid embolization, and pregnancy toxemia. Under disease conditions associated with DIC, the continuous exposure to excess TF typically exhausts the available tissue factor pathway inhibitor (TFPI), leading to rampant thrombin generation, persistent feedback activation of factor XI (FXI) by the generated thrombin, and hence virtually uncheckable ongoing fibrin generation (DIC). Recently, it was shown that patients subject to meningococcal sepsis had comparatively large amounts of mainly monocyte-derived circulating TF-containing microparticles. Because phosphatidylserine (PS) is exposed on such particles, in addition to TF, they probably contribute crucially to DIC during meningococcal sepsis. Although endothelial cells (EC) have been shown to express large amounts of TF in vitro, this observation hardly relates to the situation in vivo, where, in contrast, synthesis and exposure of EC TF is very limited and not likely to be of any significance in emerging and ongoing DIC.
Similar articles
-
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.Am J Hematol. 1996 Jul;52(3):165-70. doi: 10.1002/(SICI)1096-8652(199607)52:3<165::AID-AJH5>3.0.CO;2-R. Am J Hematol. 1996. PMID: 8756081
-
Tissue factor in health and disease.Thromb Haemost. 1997 Jul;78(1):759-64. Thromb Haemost. 1997. PMID: 9198252 Review.
-
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.Ann Hematol. 2008 Jun;87(6):451-7. doi: 10.1007/s00277-008-0446-3. Epub 2008 Feb 22. Ann Hematol. 2008. PMID: 18292996
-
No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.Crit Care Med. 2006 Oct;34(10):2646-50. doi: 10.1097/01.CCM.0000240228.43264.66. Crit Care Med. 2006. PMID: 16932226
-
Tissue factor in trauma and organ dysfunction.Semin Thromb Hemost. 2006 Feb;32(1):48-53. doi: 10.1055/s-2006-933340. Semin Thromb Hemost. 2006. PMID: 16479462 Review.
Cited by
-
M type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells.Infect Immun. 2003 Apr;71(4):1903-10. doi: 10.1128/IAI.71.4.1903-1910.2003. Infect Immun. 2003. PMID: 12654807 Free PMC article.
-
Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens.Clin Microbiol Rev. 2003 Jul;16(3):451-62. doi: 10.1128/CMR.16.3.451-462.2003. Clin Microbiol Rev. 2003. PMID: 12857777 Free PMC article. Review.
-
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.Expert Opin Ther Targets. 2022 Jan;26(1):13-28. doi: 10.1080/14728222.2022.2031975. Epub 2022 Feb 22. Expert Opin Ther Targets. 2022. PMID: 35068281 Free PMC article. Review.
-
A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.J Cancer Res Clin Oncol. 2013 Jun;139(6):1015-23. doi: 10.1007/s00432-013-1417-1. Epub 2013 Mar 15. J Cancer Res Clin Oncol. 2013. PMID: 23494077
-
Sepsis-associated disseminated intravascular coagulation and its differential diagnoses.J Intensive Care. 2019 May 20;7:32. doi: 10.1186/s40560-019-0387-z. eCollection 2019. J Intensive Care. 2019. PMID: 31139417 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous